Dr. Daniel A Vaena
Claim this profileWest Cancer Center
Area of expertise
Transitional Cell Carcinoma
Daniel A Vaena has run 3 trials for Transitional Cell Carcinoma. Some of their research focus areas include:
Bladder Cancer
Daniel A Vaena has run 3 trials for Bladder Cancer. Some of their research focus areas include:
Affiliated Hospitals
The West Clinic, P.C.
West Cancer Center & Research Institute
Clinical Trials Daniel A Vaena is currently running
Eribulin + Chemotherapy
for Bladder Cancer
This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting
2 awards
Phase 3
Disitamab Vedotin + Pembrolizumab vs Chemotherapy
for Bladder Cancer
This study will enroll participants with urothelial cancer (UC). UC can include cancer of the bladder, kidney, or the tubes that carry pee through the body (ureter, urethra). This study will try to find out if the drugs disitamab vedotin with pembrolizumab works better than platinum-containing chemotherapy to treat patients with UC. This study will also test what side effects happen when participants take these drugs together. A side effect is anything a drug does to the body besides treating the disease. Participants in this study will have cancer that has spread through the body (metastatic) or spread near where it started (locally advanced). In this study, there are 2 different groups. Participants will be assigned to a group randomly. Participants in the disitamab vedotin arm will get the study drug disitamab vedotin once every two weeks and pembrolizumab once every 6 weeks. Participants in the standard of care arm will get gemcitabine once a week for 2 weeks with either cisplatin or carboplatin once every 3 weeks.
Recruiting
2 awards
Phase 3
More about Daniel A Vaena
Clinical Trial Related
3 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Daniel A Vaena has experience with
- Nivolumab
- Docetaxel
- Pembrolizumab
- BMS-986258
- Cetuximab
- BMS-986315
Breakdown of trials Daniel A Vaena has run
Transitional Cell Carcinoma
Bladder Cancer
Urothelial Carcinoma
Prostate Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Daniel A Vaena specialize in?
Daniel A Vaena focuses on Transitional Cell Carcinoma and Bladder Cancer. In particular, much of their work with Transitional Cell Carcinoma has involved Stage IV patients, or patients who are Stage III.
Is Daniel A Vaena currently recruiting for clinical trials?
Yes, Daniel A Vaena is currently recruiting for 2 clinical trials in Memphis Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Daniel A Vaena has studied deeply?
Yes, Daniel A Vaena has studied treatments such as Nivolumab, Docetaxel, Pembrolizumab.
What is the best way to schedule an appointment with Daniel A Vaena?
Apply for one of the trials that Daniel A Vaena is conducting.
What is the office address of Daniel A Vaena?
The office of Daniel A Vaena is located at: West Cancer Center, Memphis, Tennessee 38138 United States. This is the address for their practice at the West Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.